Control of Mitochondrial Function by SPFH Proteins in Pathogenic Yeast
病原酵母中 SPFH 蛋白对线粒体功能的控制
基本信息
- 批准号:10332017
- 负责人:
- 金额:$ 11.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-16 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAntifungal AgentsAntifungal TherapyApoptosisApoptoticAreaBinding ProteinsBiological AssayBiologyBiomedical ResearchCRISPR/Cas technologyCandida albicansCarbonCell WallCell membraneCell physiologyCellsCellular AssayCessation of lifeChimeric ProteinsClustered Regularly Interspaced Short Palindromic RepeatsCo-ImmunoprecipitationsComplementComplexDisseminated candidiasisDrug usageEpitopesEukaryotaEukaryotic CellExposure toFamilyFamily memberFilamentFlow CytometryFluorescence MicroscopyFundingGenesGeneticGenetic TranscriptionGoalsGrowthHispanic-serving InstitutionHumanHyphaeInfectionInterventionInvertebratesInvestigationKnowledgeLeishmaniaLifeLife Cycle StagesMammalsMediatingMembraneMembrane PotentialsMembrane ProteinsMitochondriaMolecularMolecular BiologyMolecular GeneticsMorphogenesisNematodaOrganellesOxidative StressParasite ControlParasitesPathogenesisPathogenicityPathway interactionsPatientsPhenotypePhospholipidsPlanariansPlasmodiumProcessProductionProductivityPropertyProtein FamilyProtein Sequence AnalysisProteinsProteomicsPublishingReactive Oxygen SpeciesResearchRespirationRoleSavingsSignal TransductionSourceStressStudentsStudy modelsSystemTestingTimeTrainingVertebratesVirulenceYeastsbasecandidemiacollegecost effectivedrug efficacyflotillinfungusgene discoverygenome editinghuman pathogenin vivoinhibitor/antagonistinnovationlight microscopymembermicrobialmitochondrial membranemortalitymutantnovelpathogenpathogenic fungusprogramsprohibitinprotein complexprotein functionrespiratoryresponse
项目摘要
The mitochondrion is the major energy-producing organelle of the cell and coordinates key activities such
as signaling, apoptosis, and phospholipid synthesis. These processes are essential for survival and
pathogenesis of Candida albicans, the most common fungal pathogen in humans. C. albicans respiration
occurs via three distinct pathways compared to vertebrates and is associated with virulence properties such
as morphogenesis and cell wall synthesis. Our long-term research goal is to understand the cellular and
molecular mechanisms that govern C. albicans survival in response to environmental stress and antifungal
drugs. We previously discovered that gene classes involved mitochondrial functions are highly transcribed
in response to osmotic and cell wall stress, and the gene SLP3 (stomatin like protein 3) was significantly
upregulated. SLP3 is a member of the conserved SPFH (Stomatin, Prohibitin, Flotillin, HflK/HflC) protein
superfamily. In eukaryotes, SPFH proteins are required for essential mitochondrial processes such as
respiration, mitophagy, and apoptosis and mediate pathogenicity in several parasites. Our objective in this
proposal is to determine the role of the C. albicans SPFH protein family in mitochondrial function. We were
the first to demonstrate that Slp3p overproduction disrupted mitochondrial membrane potential and
triggered apoptotic-like death specifically following prolonged exposure to oxidative stress. However, the
molecular function Slp3p remains unknown. Thus, our central hypothesis is that C. albicans SPFH proteins
form membrane complexes to coordinate mitochondrial function. This hypothesis is based upon
observations with mammalian SPFH proteins and our published and preliminary findings. Human SPFH
complexes appear as punctate foci when viewed using fluorescence microscopy. We found that Slp3p form
puncta at the plasma membrane. Further, we identified a mitochondrial targeting signal in Slp2p, Phb1p and
Phb2p, and our Slp2p-GFP fusion protein formed mitochondrial puncta. We will utilize a high-throughput
molecular genetic and cellular approach that is cost-effective and time-saving to determine SPFH protein
localization, protein complex composition, cellular function, and role in C. albicans infection. We will create
SPFH-GFP fusion proteins and use fluorescence microscopy to determine cellular localization. We will
construct SPFH-epitope-tagged strains and perform Co-IP and LC-MS/MS analyses to identify putative
SPFH protein binding partners. We will create SPFH mutants via CRISPR-Cas9 genome editing and
phenotypically characterize mutant strains in growth and cellular assays. We will examine SPFH function in
C. albicans pathogenesis using a novel invertebrate infection system. Our findings will address a poorly
understood area in C. albicans biology and provide a model for studying SPFH proteins in pathogenic fungi.
This proposal is innovative as we will characterize the SPFH family in the context of a critical, yet poorly
understood area in C albicans biology: the molecular framework underlying mitochondrial function.
线粒体是细胞主要产生能量的细胞器,协调关键活动,例如
如信号传导、细胞凋亡和磷脂合成。这些过程对于生存和发展至关重要
白色念珠菌(人类最常见的真菌病原体)的发病机制。白色念珠菌呼吸
与脊椎动物相比,它通过三种不同的途径发生,并且与毒力特性相关,例如
如形态发生和细胞壁合成。我们的长期研究目标是了解细胞和
控制白色念珠菌响应环境应激和抗真菌生存的分子机制
药物。我们之前发现涉及线粒体功能的基因类别是高度转录的
响应渗透压和细胞壁应激,基因 SLP3(stomatin 样蛋白 3)显着
上调。 SLP3 是保守的 SPFH(Stomatin、Prohibitin、Flotillin、HflK/HflC)蛋白的成员
超家族。在真核生物中,SPFH 蛋白是线粒体重要过程所必需的,例如
呼吸、线粒体自噬和细胞凋亡并介导多种寄生虫的致病性。我们的目标是
该提案旨在确定白色念珠菌 SPFH 蛋白家族在线粒体功能中的作用。我们是
第一个证明 Slp3p 过量产生会破坏线粒体膜电位,
特别是在长期暴露于氧化应激后,会引发细胞凋亡样死亡。然而,
Slp3p 的分子功能仍然未知。因此,我们的中心假设是白色念珠菌 SPFH 蛋白
形成膜复合物以协调线粒体功能。这个假设是基于
对哺乳动物 SPFH 蛋白的观察以及我们已发表的初步发现。人类SPFH
当使用荧光显微镜观察时,复合物显示为点状焦点。我们发现Slp3p形式
质膜上的斑点。此外,我们在 Slp2p、Phb1p 和
Phb2p 和我们的 Slp2p-GFP 融合蛋白形成线粒体斑点。我们将利用高通量
分子遗传学和细胞方法可经济高效且节省时间地测定 SPFH 蛋白
定位、蛋白质复合物组成、细胞功能以及在白色念珠菌感染中的作用。我们将创造
SPFH-GFP 融合蛋白并使用荧光显微镜确定细胞定位。我们将
构建 SPFH 表位标记菌株并进行 Co-IP 和 LC-MS/MS 分析以鉴定假定的菌株
SPFH 蛋白结合伴侣。我们将通过 CRISPR-Cas9 基因组编辑创建 SPFH 突变体
在生长和细胞测定中表征突变菌株的表型特征。我们将检查 SPFH 的功能
使用新型无脊椎动物感染系统的白色念珠菌发病机制。我们的研究结果将解决一个问题
理解白色念珠菌生物学领域,并为研究病原真菌中的 SPFH 蛋白提供模型。
该提案具有创新性,因为我们将在一个关键但效果不佳的背景下描述 SPFH 家族的特征。
白色念珠菌生物学的理解领域:线粒体功能的分子框架。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason Malcolm Rauceo其他文献
Jason Malcolm Rauceo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason Malcolm Rauceo', 18)}}的其他基金
Control of Mitochondrial Function by SPFH Proteins in Pathogenic Yeast
病原酵母中 SPFH 蛋白对线粒体功能的控制
- 批准号:
10674870 - 财政年份:2021
- 资助金额:
$ 11.91万 - 项目类别:
Analysis of the Candida albicans adhesin Als5p
白色念珠菌粘附素 Als5p 的分析
- 批准号:
6807048 - 财政年份:2003
- 资助金额:
$ 11.91万 - 项目类别:
Analysis of the Candida albicans adhesin Als5p
白色念珠菌粘附素 Als5p 的分析
- 批准号:
6942241 - 财政年份:2003
- 资助金额:
$ 11.91万 - 项目类别:
Analysis of the Candida albicans adhesin Als5p
白色念珠菌粘附素 Als5p 的分析
- 批准号:
6741334 - 财政年份:2003
- 资助金额:
$ 11.91万 - 项目类别:
相似国自然基金
典型唑类抗真菌剂在斑马鱼中的富集代谢规律及其性腺激素干扰效应研究
- 批准号:21507163
- 批准年份:2015
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
群体感应系统阻遏抗真菌剂藤黄绿菌素生物合成的分子机制
- 批准号:31270083
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
抗真菌剂藤黄绿菌素生物合成自诱导的分子机理研究
- 批准号:30800009
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of M-Drive: A recyclable Mucor-optimized CAS9 gene-drive system cable of multi-target gene editing
开发M-Drive:可回收的多靶点基因编辑的毛霉优化CAS9基因驱动系统电缆
- 批准号:
10727359 - 财政年份:2023
- 资助金额:
$ 11.91万 - 项目类别:
Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
开发一种针对糖基磷脂酰肌醇 (GPI) 生物合成和细胞壁生物合成的新型广谱抗真菌治疗药物
- 批准号:
10759723 - 财政年份:2023
- 资助金额:
$ 11.91万 - 项目类别:
Antifungals targeting pantothenate phosphorylation
靶向泛酸磷酸化的抗真菌药
- 批准号:
10696567 - 财政年份:2023
- 资助金额:
$ 11.91万 - 项目类别:
Targeted pan-antibacterial liposomes to control pathogenic mycobacteria
靶向泛抗菌脂质体控制致病性分枝杆菌
- 批准号:
10569282 - 财政年份:2023
- 资助金额:
$ 11.91万 - 项目类别:
Filling gaps in the cryptococcal wall with glycogen and a novel enzyme
用糖原和一种新型酶填充隐球菌壁的间隙
- 批准号:
10648839 - 财政年份:2023
- 资助金额:
$ 11.91万 - 项目类别: